CTLA4 and head and neck squamous cell carcinoma: Multiple mechanisms may contribute to HNSCC evasion of antitumor immunity, including the frequent upregulation of immune checkpoint molecules such as PD-1, programmed death-ligand 1 (PD-L1), and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) [9].